Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00945191 · ClinicalTrials.gov registry record · Phase 2
Combination Chemotherapy With CS-1008 to Treat Ovarian Cancer
A Phase 2 study, sponsored by Daiichi Sankyo.
- Completed
- Registry status
- Phase 2
- Development phase
- 24
- Enrollment target
NCT00945191 is a Phase 2 study that has completed, run by Daiichi Sankyo. The registered enrollment target is 24 participants.
The verdict
NCT00945191, a Phase 2 study, has completed, sponsored by Daiichi Sankyo.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 24 participants
- Enrollment target
Study Summary
This trial assessed the effect of treatment with CS-1008 in combination with paclitaxel/carboplatin on response in patients with locally advanced or metastatic ovarian cancer.
Interventions
- DRUG Carboplatin
- DRUG Paclitaxel
- DRUG CS-1008
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2009-10-06 |
| Est. Completion | 2011-08-23 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00945191
The ClinicalTrials.gov registry entry for NCT00945191 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Daiichi Sankyo, which has 236 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Carboplatin is the first listed.
NCT00945191 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00945191 about?
NCT00945191 is a clinical study titled "Combination Chemotherapy With CS-1008 to Treat Ovarian Cancer". This trial assessed the effect of treatment with CS-1008 in combination with paclitaxel/carboplatin on response in patients with locally advanced or metastatic ovarian cancer.
What is the current status of trial NCT00945191?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 24 participants. The study started on 2009-10-06. Estimated completion is 2011-08-23.
What interventions are being tested in trial NCT00945191?
The interventions under investigation include: Carboplatin (DRUG), Paclitaxel (DRUG), CS-1008 (DRUG).
Who is sponsoring clinical trial NCT00945191?
This trial is sponsored by Daiichi Sankyo, which has 236 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.